Atividade das ectonucleotidases, colinesterase sérica e perfil oxidativo no diabetes melito tipo 2 e hipertensão em humanos

• Autor(a) principal: Lunkes, Gilberto Inácio
• Data de Publicação: 2008
• Tipo de documento: Tese
• Idioma: por
• Título da fonte: Manancial - Repositório Digital da UFSM
• dARK ID: ark:/26339/00130000034cx
• Texto Completo: http://repositorio.ufsm.br/handle/1/4394
• topic: Ectonucleotidases; Estresse oxidativo; Colinesterase sérica; Diabetes melito tipo 2; Hipertensão; Humanos; Plaquetas; Ectonucleotidases; Oxidative profile; Serum cholinesterase; Type 2 Diabetes melito; Hypertension; Platelets; CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA

The increase in the NTPDase and 5'-nucleotidase enzymatic activities, in patients with diabetes and hypertension, unchained the investigation of the possible mechanisms involved in the alterations in ectonucleotidases activities. The oxidative stress level and also the answer of the antioxidant systems were evaluated in patients with type 2 diabetes, hypertension and type 2 diabetes with associated hypertension. The interference of the glucose concentration was evaluated in the enzymatic activity of the ectonucleotidases, serum cholinesterase and also antioxidant enzymes. The curves in vitro demonstrated that the increase in enzymatic activity was proportional to the elevation in the glucose concentrations, demonstrating a direct interference of the hyperglycemia. The increase in the NTPDase expression demonstrated an important correlation with adenine nucleotide ATP and ADP hydrolyze in patients with diabetes and associated hypertension. The increment in markers of oxidative stress and antioxidant systems levels in patients with diabetes and associated hypertension seems to be related with a compensatory mechanism to prevent oxidative damages. Low serum acid ascorbic levels increase exposes to oxidative damages in patients with diabetes and associated hypertension, resultant of the increase in reactive oxygen species generation. The increment in the serum cholinesterase activity can be potentially related with glycemia levels and lipid metabolism in patients with diabetes and associated hypertension. The medicines administered to the patients did not alter the enzymatic responses in the analyzed groups. Therefore, there were a possible interference of the diabetes and hypertension in the catalytic mechanism of the serum cholinesterase enzyme. Data obtained in the studies permit to suggest that high blood glucose levels constitute one of the principal factors capable to promote alterations in the enzymatic responses in patients with diabetes and associated hypertension.